Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2002
12/11/2002EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002EP1263427A1 Il-8 receptor antagonists
12/11/2002EP1058678B1 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
12/11/2002EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002EP0923568B1 Novel benzofuran-4-carboxamides
12/11/2002EP0920456B1 Phosgenated oxime resins and their preparation
12/11/2002EP0912540B1 Process for preparing phthalides
12/11/2002EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/11/2002EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002CN1384821A Method for improving solubility of tricyclic amino alcohol derivatives
12/11/2002CN1384103A Carbofuran half-antigen, antigen and antibody and their prepn process
12/11/2002CN1384090A Extraction process of tanshin general phenolic acid and its prepn and use
12/11/2002CN1095845C Method and device for production of lyophilized hydrochloride-1 beta, 10 beta-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
12/11/2002CN1095842C Prep. of cyclopropane derivatives with anti-virus effectiveness and intermediate therefor
12/10/2002US6492562 Invention also relates to novel intermediates and the resulting modified polyketides and antibiotics.
12/10/2002US6492539 Preparation of preparing substituted indanones
12/10/2002US6492535 Process for the production of gamma-butyrolactone
12/10/2002US6492532 Method for producing carbonyl compound by dehydrogenating alcohol
12/10/2002US6492513 Method for separating a lactone-containing high-molecular weight compound having an alkyl group as its side chain from a lactone-containing high-molecular weight compound having an alkenyl group as its side chain, said lactone-containing
12/10/2002US6492423 Hepatitis c and b viricides
12/10/2002US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002US6492413 For use in therapy of pain, arthritis, fever
12/10/2002US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002US6492396 Substituted thioacetamides
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002US6492374 Benzofuran derivatives, their preparation and use
12/10/2002US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002US6492342 Hygromycin A prodrugs
12/10/2002US6492338 Therapeutic agents
12/10/2002CA2036360C Reagents and methods for stereospecific fluoromethylation
12/05/2002WO2002096901A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/05/2002WO2002096898A2 Process for the preparation of prostaglandins and analogues thereof
12/05/2002WO2002096884A2 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
12/05/2002WO2002096882A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
12/05/2002WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
12/05/2002WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002WO2002057247A3 Addition of mineral acids or salts thereof to a trimellitic acid anhydride production process
12/05/2002WO2001093840A2 Ligands of integrin receptors
12/05/2002US20020183558 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
12/05/2002US20020183529 Novel tetrahydrofuran compounds having alicyclic structure
12/05/2002US20020183528 Alternatives for isocyanates in coating compositions and application processes
12/05/2002US20020183512 Compounds for use in treatment of cancer
12/05/2002US20020183449 Curable compounds, curable resin compositions containing the same and methods of easily disassembling cured materials
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183362 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
12/05/2002US20020183361 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
12/05/2002US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002US20020182232 Naphthofurandione dyes
12/05/2002DE10232967A1 Oxidation synthesizing reactor for e.g. synthesis of phthalic acid anhydride, comprises diagonal-action impeller wheel with heat medium throttle gap parallel to shaft
12/05/2002CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002CA2448160A1 Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
12/05/2002CA2448088A1 Process for the preparation of prostaglandins and analogues thereof
12/05/2002CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002CA2445647A1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
12/05/2002CA2411549A1 Ligands of integrin receptors
12/05/2002CA2411082A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
12/04/2002EP1262481A1 Indanone derivatives for use as fragrances
12/04/2002EP1261597A1 Method for producing maleic acid anhydride
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261424A1 Hollow cylindrical catalyst and a method for producing a maleic acid anhydride
12/04/2002EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002EP1027343B1 Process for the preparation of hydroxy substituted gamma butyrolactones
12/04/2002EP0904268B1 Processes for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxazines
12/04/2002EP0863890B1 5-amidomethyl alpha, betha-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents
12/04/2002CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/04/2002CN1095465C Chiral anonance-lactone compounds, and its synthesizing process and application
12/04/2002CN1095400C Catalyst for preparing gamma-butyrolactone from cis-aldehyde by ordinary-pressure gas-phase hydrogenation and its use
12/04/2002CN1095397C Catalyst for preparing furan by gas-phase decarbonxylation of furaldehyde
12/03/2002US6489521 Fixed bed catalysts
12/03/2002US6489492 Disodium(2s,3s)-tetrahydro-3-hydroxy-5-oxo-2,3-furandicarboxylate for example, as well as corresponding acyl halides, esters, cyclic imides, and protected hydroxyl derivates thereof
12/03/2002US6489489 Organic electroluminescent device
12/03/2002US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002US6489327 Tryptase inhibitors
12/03/2002US6488818 Removal of impurities from 3-(2′-acetoxyethyl)-dihydro-2(3H)furanone
12/03/2002CA2253061C A novel anti-allergy anti-inflammatory composition
12/03/2002CA2052365C Substituted cyclopentenyl-oxabicyclooctanes, cyclopentenyl-formylcyclohexenes, cyclopentenyl-hydroxymethyl cyclohexenes and camphonyl spirocyclooxaoctane-containing compositions, organoleptic uses thereof and process for preparing same
11/2002
11/28/2002WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
11/28/2002WO2002094794A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094760A2 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
11/28/2002WO2002094262A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/28/2002WO2002074718A3 Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures
11/28/2002WO2002009759A3 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
11/28/2002US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders